Xenitra Limited
Research Xenitra Limited (XEN) on Bullrun: market cap AUD 11.74M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerXEN
- ExchangeAU
- CountryAustralia
- SectorConsumer Cyclical
- IndustryDepartment Stores
- CurrencyAUD
- Market capAUD 11.74M
- Financial periodFY2025
- RevenueAUD 39.77M
- Revenue growth53.7%
- Net income-AUD 3.48M
- Free cash flow-AUD 4.26M
- Gross margin2.4%
Valuation Snapshot
latest market cap is AUD 11.74M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 39.77M | -AUD 3.48M | -AUD 4.26M | 2.4% | 0 | AUD 1.68M | AUD 1.16M | AUD 2.55M |
| FY2024 | AUD 25.87M | -AUD 6.28M | -AUD 2.84M | 3.3% | 0 | AUD 1.99M | AUD 2.19M | AUD 524.74K |
| FY2023 | AUD 2.67M | -AUD 3.03M | -AUD 3.46M | 2.3% | 0 | AUD 1.39M | n/a | AUD 5.11M |
| FY2022 | AUD 6.01M | -AUD 6.18M | -AUD 6.26M | 9.2% | -0.01 | AUD 3.04M | AUD 520.24K | AUD 4.13M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-27 | AUD 11.74M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Xenitra Limited
Xenitra Limited operates as a brand acceleration, market-access, and distribution company in Australia, Hong Kong, and Mainland China. It offers functional and medical food, such as infant formula, and vitamin mineral and supplement category products; over the counter products, such as non-prescription small molecule medicines and structure function benefit complementary medicines; fast-moving consumer goods (FMCG); nutraceuticals; health and wellness;
Related stock research
Other Consumer Cyclical stocks
Frequently asked questions
What is Xenitra Limited's market cap?
Xenitra Limited's market capitalization is AUD 11.74M.
What does Xenitra Limited do?
Xenitra Limited operates as a brand acceleration, market-access, and distribution company in Australia, Hong Kong, and Mainland China. It offers functional and medical food, such as infant formula, and vitamin mineral and supplement category products; over the counter products, such as non-prescription small molecule medicines and structure function benefit complementary medicines; fast-moving consumer goods (FMCG); nutraceuticals; health and wellness; and personal care products, as well as involved in real world asset tokenisation and nutritional product trading.